They are different measurement systems
Although GLP-1RAs have revolutionized metabolic disease management, their potential therapeutic role in ocular diseasesparticularly those driven by shared metabolic and inflammatory pathwaysremains underexplored, despite growing preclinical evidence
Importantly, despite the evidence for use of SGLT-2 inhibitors for DKD treatment, they should not be used in patients with type 1 diabetes because of the risk of euglycaemic diabetic ketoacidosis
It was ideal for extra 2-3 urinations the first day
Pricing dramatically below market average is the most obvious red flag
Our monthly fee is all-inclusive, covering your medical consultations, personalized dosing plan, the medication itself, and shipping